Agile therapeutics, inc. reports earnings results for the third quarter ended september 30, 2019

Agile therapeutics, inc. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced operating loss was usd 4.499 million compared to usd 3.615 million a year ago. net loss was usd 4.432 million compared to usd 3.792 million a year ago. basic loss per share from continuing operations was usd 0.08 compared to usd 0.11 a year ago. for the nine months, operating loss was usd 12.753 million compared to usd 15.809 million a year ago. net loss was usd 12.585 million compared to usd 15.969 million a year ago. basic loss per share from continuing operations was usd 0.28 compared to usd 0.47 a year ago.
AGRX Ratings Summary
AGRX Quant Ranking